Tokyo Tape
Sign in
← Medipal Holdings

Quarterly report · Q3

7459.TEDINET S100Q61E
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥2.57T2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥3.29T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥2.51T2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥37.5bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥37.0bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥49.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥62.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥51.8bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥56.7bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥52.2bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥29.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥28.8bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥37.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥36.7bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥1.81Tat 2022-12-31Cons.Assets
Total assets¥1.71Tat 2022-03-31Cons.Assets
Total assets¥1.78Tat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥1.13Tat 2022-12-31Cons.Liabilities
Total liabilities¥1.06Tat 2022-03-31Cons.Liabilities
Net assets / equity¥678.0bnat 2022-12-31Cons.Net assets
Net assets / equity¥649.1bnat 2022-03-31Cons.Net assets
Net assets / equity¥649.5bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥252.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥243.2bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥142.162022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.652022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥140.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥137.322021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥49.092021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥136.42022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥131.412021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥128.872021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio30.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio29.9%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥7.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥7.0bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31¥44m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥56.2bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥56.2bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue2022-04-01 → 2022-12-31¥848.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue external2022-04-01 → 2022-12-31¥847.9bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥253m
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.1bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.67T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.66T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.7bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥16.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥2.57T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥2.57T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥7.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥37.5bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥2.8bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥2.8bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31¥391m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥54.8bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥54.8bn
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥2m
jpcrp040300-q3r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.2bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue2021-04-01 → 2021-12-31¥802.1bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue external2021-04-01 → 2021-12-31¥801.8bn
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥260m
jpcrp040300-q3r_E02632-000Cosmetics Daily Necessitiesreportable segmentsegment profit2021-04-01 → 2021-12-31¥20.2bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥1.65T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥1.65T
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥2.6bn
jpcrp040300-q3r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥14.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥2.51T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥2.51T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥2.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥36.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 384
ItemContextValueUnit
Gain on sales of noncurrent assets eiCurrentYTDDuration48000000JPY
Gain on sales of investment securities eiPrior1YTDDuration48000000JPY
Gain on sales of investment securities eiCurrentYTDDuration13044000000JPY
Insurance income eiPrior1YTDDuration333000000JPY
Insurance income eiCurrentYTDDuration－JPY
Other eiPrior1YTDDuration102000000JPY
Other eiCurrentYTDDuration10000000JPY
Extraordinary incomePrior1YTDDuration508000000JPY
Extraordinary incomeCurrentYTDDuration13103000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration41000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration161000000JPY
Impairment loss elPrior1YTDDuration61000000JPY
Impairment loss elCurrentYTDDuration106000000JPY
Loss on valuation of investment securities elPrior1YTDDuration17000000JPY
Loss on valuation of investment securities elCurrentYTDDuration5812000000JPY
Other elPrior1YTDDuration2000000JPY
Other elCurrentYTDDuration258000000JPY
Extraordinary lossPrior1YTDDuration123000000JPY
Extraordinary lossCurrentYTDDuration6338000000JPY
Income before income taxesPrior1YTDDuration52226000000JPY
Income before income taxesCurrentYTDDuration56673000000JPY
Income taxes currentPrior1YTDDuration16077000000JPY
Income taxes currentCurrentYTDDuration22146000000JPY
Income taxes deferredPrior1YTDDuration-530000000JPY
Income taxes deferredCurrentYTDDuration-2606000000JPY
Income taxesPrior1YTDDuration15546000000JPY
Income taxesCurrentYTDDuration19539000000JPY
Profit lossPrior1YTDDuration36680000000JPY
Profit lossCurrentYTDDuration37134000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration7847000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration7285000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration28832000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration29848000000JPY
Profit lossPrior1YTDDuration36680000000JPY
Profit lossCurrentYTDDuration37134000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-11045000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration3174000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration-0JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-34000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-201000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-374000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration256000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration1086000000JPY
Other comprehensive incomePrior1YTDDuration-10991000000JPY
Other comprehensive incomeCurrentYTDDuration3852000000JPY
Comprehensive incomePrior1YTDDuration25688000000JPY
Comprehensive incomeCurrentYTDDuration40986000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration19053000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration32866000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration6635000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass